53,448 Shares in LifeStance Health Group, Inc. $LFST Acquired by Global Retirement Partners LLC

Global Retirement Partners LLC acquired a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 53,448 shares of the company’s stock, valued at approximately $572,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Larson Financial Group LLC boosted its position in LifeStance Health Group by 19,952.6% during the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after purchasing an additional 3,791 shares in the last quarter. KBC Group NV acquired a new stake in LifeStance Health Group in the first quarter valued at $29,000. EverSource Wealth Advisors LLC increased its position in shares of LifeStance Health Group by 359.1% in the first quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock valued at $44,000 after buying an additional 5,404 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of LifeStance Health Group by 615.3% in the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after buying an additional 7,987 shares in the last quarter. Finally, Assetmark Inc. raised its stake in shares of LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock worth $60,000 after buying an additional 1,367 shares during the last quarter. 85.50% of the stock is owned by institutional investors and hedge funds.

LifeStance Health Group Stock Performance

NASDAQ LFST opened at $12.36 on Wednesday. LifeStance Health Group, Inc. has a fifty-two week low of $4.77 and a fifty-two week high of $12.76. The stock has a market cap of $4.79 billion, a price-to-earnings ratio of 95.08 and a beta of 1.14. The business has a fifty day moving average of $10.58 and a 200-day moving average of $8.30. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. The business had revenue of $435.35 million for the quarter, compared to analyst estimates of $414.58 million. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The business’s revenue for the quarter was up 26.1% compared to the same quarter last year. During the same quarter last year, the company earned ($0.01) earnings per share. As a group, analysts predict that LifeStance Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

LFST has been the topic of several recent research reports. JPMorgan Chase & Co. boosted their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a research report on Friday, August 14th. The Goldman Sachs Group started coverage on shares of LifeStance Health Group in a report on Friday, June 5th. They set a “neutral” rating and a $9.00 target price for the company. Barclays lifted their target price on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. BTIG Research upped their price target on shares of LifeStance Health Group from $15.00 to $16.00 and gave the company a “buy” rating in a report on Friday, August 7th. Finally, Wall Street Zen upgraded shares of LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $12.12.

Insider Activity

In other LifeStance Health Group news, Director Robert Bessler sold 894,337 shares of the company’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $10.13, for a total value of $9,059,633.81. Following the transaction, the director directly owned 539,763 shares in the company, valued at approximately $5,467,799.19. This represents a 62.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CTO Vukasin Paunovich sold 44,394 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $10.85, for a total transaction of $481,674.90. Following the sale, the chief technology officer directly owned 247,446 shares in the company, valued at $2,684,789.10. This represents a 15.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 14,629,850 shares of company stock valued at $154,952,012 in the last 90 days. Company insiders own 3.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.